Department of Internal Medicine, Chonnam National University and Hospital, Gwangju, Korea.
Respiration. 2011;82(2):124-9. doi: 10.1159/000320254. Epub 2010 Oct 8.
In 2007, the American Thoracic Society (ATS) and Infectious Disease Society of America (IDSA) published new diagnostic guidelines for nontuberculous mycobacterial (NTM) disease. Bacteriological criteria have become simpler compared to the 1997 ATS diagnostic criteria.
For assessing the impact of the 2007 ATS/IDSA diagnostic criteria, we compared the diagnosis rate and time to diagnosis of NTM lung disease using the 1997 and 2007 ATS guidelines.
Sixty-four patients who had excreted Mycobacterium intracellulare, M. avium, M. abscessus or M. kansasii at least one time in their respiratory specimens at Chonnam National University Hospital were reviewed. The 1997 ATS and 2007 ATS/IDSA guidelines were applied to these patients.
Thirty-seven of 64 patients (57.8%) were diagnosed with NTM lung disease by the 1997 ATS criteria. When the 2007 ATS/IDSA criteria were applied, 6 patients were newly diagnosed with NTM lung disease. The diagnosis rate significantly increased from 57.8 to 67.2% (p < 0.001). The time to diagnosis in the 1997 ATS and 2007 ATS/IDSA guidelines was 46.4 ± 53.0 and 36.2 ± 38.5 days, respectively (p = 0.002).
These data suggest that we can shorten the time to diagnose NTM lung disease and diagnose more simply by using the 2007 ATS/IDSA guidelines. Further study will be needed to assess that these changes affect the management of NTM disease.
2007 年,美国胸科学会(ATS)和传染病学会(IDSA)发布了非结核分枝杆菌(NTM)病的新诊断指南。与 1997 年 ATS 诊断标准相比,细菌学标准变得更加简单。
为了评估 2007 年 ATS/IDSA 诊断标准的影响,我们比较了使用 1997 年和 2007 年 ATS 指南时 NTM 肺病的诊断率和诊断时间。
回顾了在全南国立大学医院至少一次从呼吸道标本中排出细胞内分枝杆菌、鸟分枝杆菌、脓肿分枝杆菌或堪萨斯分枝杆菌的 64 例患者。对这些患者应用 1997 年 ATS 和 2007 年 ATS/IDSA 指南。
37 例患者(57.8%)符合 1997 年 ATS 标准诊断为 NTM 肺病。当应用 2007 年 ATS/IDSA 标准时,有 6 例患者新诊断为 NTM 肺病。诊断率从 57.8%显著增加到 67.2%(p<0.001)。1997 年 ATS 和 2007 年 ATS/IDSA 指南的诊断时间分别为 46.4±53.0 和 36.2±38.5 天(p=0.002)。
这些数据表明,我们可以通过使用 2007 年 ATS/IDSA 指南缩短诊断 NTM 肺病的时间,并简化诊断。需要进一步研究来评估这些变化是否影响 NTM 病的管理。